1-3 of 3
Andrea Cremaschi, PhD
Close
Sort by
Journal Articles

Ex Vivo Drug Sensitivity Screens Identify Personalized Treatment Options for CLL Patients

Sigrid Strand Skånland, PhD, Bendiksen Henrik, MSc, Andrea Cremaschi, PhD, Deepak Balaji Thimiri Govinda Raj, PhD, Ludvig Andre Munthe, MD PhD, Geir Erland Tjønnfjord, MD PhD, Kjetil Taskén, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5446.
https://doi.org/10.1182/blood-2019-121890
Published: 2019
Journal Articles

In-Vitro Drug Sensitivity Screening in Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples Identifies Drug Candidates for Precision Cancer Therapy

Deepak Balaji balaji Thimiri Govinda Raj, PhD MSc, Andrea Cremaschi, PhD MSc, Sigrid Strand Skånland, PhD, Alexandra Gade, Fredrik H. Schjesvold, MD PhD, Geir Erland Tjønnfjord, MD DMsc, Ludvig A Munthe, Kjetil Tasken
Journal: Blood
Blood (2018) 132 (Supplement 1): 4676.
https://doi.org/10.1182/blood-2018-99-110357
Published: 2018
Journal Articles

Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy

Deepak Balaji balaji Thimiri Govinda Raj, PhD MSc, Mariaserena Giliberto, Andrea Cremaschi, PhD MSc, Sigrid Strand Skånland, PhD, Alexandra Gade, Geir Erland Tjønnfjord, MD DMsc, Fredrik H. Schjesvold, MD PhD, Ludvig Andre Munthe, MD PhD, Kjetil Tasken
Journal: Blood
Blood (2018) 132 (Supplement 1): 4677.
https://doi.org/10.1182/blood-2018-99-110669
Published: 2018